Haifa, Israel

Nadav Shapira

This inventor holds 1 USPTO granted patent. Top assignee: Novocure Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nadav Shapira. Retrieved from https://idiyas.com/inventor/nadav-shapira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nadav Shapira and Patent Innovation in Tumor-Treating Field Planning.

Introduction

Nadav Shapira is an inventor associated with Haifa, Israel, and Novocure GmbH. His patent work addresses how treatment-array layouts can account for tumor progression when planning the delivery of tumor-treating fields.

Latest Patents

Shapira is associated with 1 patent, titled “Adapting Array Layouts to Account for Tumor Progression.” The patent describes a computer-implemented method that uses a three-dimensional, voxel-based model of a subject to identify the tumor’s current location, an expanded primary clinical target volume, and a larger predictive clinical target volume representing a possible future location. It then selects one or more transducer layouts based on the primary and predictive target volumes, with the aim of adapting tumor-treating field delivery to anticipated progression.

Career Highlights

Shapira’s listed patent reflects work at the intersection of computational modeling, treatment planning, and medical-device technology. His association with Novocure GmbH connects his invention to the development of approaches for delivering tumor-treating fields.

Collaborations

Brian Berger is identified as Shapira’s coworker. The available information does not specify their particular projects or contributions to the patent.

Conclusion

Nadav Shapira’s patent focuses on using current and predicted tumor locations to guide transducer-array selection, illustrating how modeling can inform treatment planning for tumor-treating fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…